Literature DB >> 19211095

Occult thyroid eye disease in patients presenting with dry eye symptoms.

Anita Gupta1, Pooyan Badihian Sadeghi, Esen Karamursel Akpek.   

Abstract

PURPOSE: To describe the clinical presentation, laboratory features, and treatment outcomes in a series of patients with occult thyroid eye disease (TED).
DESIGN: Retrospective observational case series.
METHODS: Among 539 patients who were referred for dry eye evaluation over 2 years, 21 were diagnosed with occult TED, based on typical findings in orbital echography. Medical records of these patients were reviewed to collect information on demographics, clinical findings, laboratory studies, and treatment response.
RESULTS: All patients presented with symptoms of dry eye. Median age of patients was 57 years (range, 24 to 78 years), with the majority female (86%). No patients carried prior diagnosis of TED or had typical findings of TED such as proptosis, dysmotility, or diplopia. Suspicion of TED was based on conjunctival hyperemia with or without chemosis localized to extraocular muscles (100%), and subtle widening of interpalpebral fissure (48%). Clinical findings included corneal fluorescein staining (57%), rapid tear break-up time (31%), and abnormal Schirmer test (19%). Nineteen percent of patients had other rheumatologic disorders commonly associated with dry eye: Sjögren syndrome (n = 3), and rheumatoid arthritis (n = 1). Patients were treated topically using cyclosporine 0.05% 2 to 4 times a day, with or without steroid. Other treatments were also employed as necessary including warm compresses, artificial tears, and puntal plugs. Majority of patients (76%) had improvement of their symptoms.
CONCLUSION: Occult TED is a potential cause of inflammatory ocular surface disease with dry eye symptomatology and should be considered in the differential diagnosis when evaluating dry eye patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211095     DOI: 10.1016/j.ajo.2008.12.007

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  26 in total

1.  Ocular changes and approaches of ophthalmopathy in basedow - graves- parry- flajani disease.

Authors:  George Saraci; Anamaria Treta
Journal:  Maedica (Buchar)       Date:  2011-04

2.  Association of Dry Eye Tests With Extraocular Signs Among 3514 Participants in the Sjögren's Syndrome International Registry.

Authors:  Vatinee Y Bunya; Satasuk Joy Bhosai; Ana Maria Heidenreich; Kazuko Kitagawa; Genevieve B Larkin; Thomas M Lietman; Bruce D Gaynor; Esen K Akpek; Mina Massaro-Giordano; M Srinivasan; Travis C Porco; John P Whitcher; Stephen C Shiboski; Lindsey A Criswell; Caroline H Shiboski
Journal:  Am J Ophthalmol       Date:  2016-09-16       Impact factor: 5.258

3.  Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.

Authors:  Danping Huang; Nuo Xu; Yiyue Song; Peijuan Wang; Huasheng Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-30       Impact factor: 3.117

4.  Graves' Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis.

Authors:  Irini P Chatziralli; Evgenia Kanonidou; Petros Keryttopoulos; Dionyssia Papadopoulou; Leonidas Papazisis
Journal:  Case Rep Ophthalmol       Date:  2010-09-13

5.  The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Lelio Baldeschi; Kostas Boboridis; Anja Eckstein; George J Kahaly; Claudio Marcocci; Petros Perros; Mario Salvi; Wilmar M Wiersinga
Journal:  Eur Thyroid J       Date:  2016-03-02

6.  The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

Authors:  Jelena Juri Mandić; Ana Kozmar; Sanja Kusačić-Kuna; Anamarija Jazbec; Krešimir Mandić; Danijela Mrazovac; Nenad Vukojević
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-14       Impact factor: 3.117

7.  Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy.

Authors:  KeBo Cai; RuiLi Wei
Journal:  Endocrine       Date:  2012-11-28       Impact factor: 3.633

8.  Relationships between activated dendritic cells and dry eye symptoms and signs.

Authors:  Harry Levine; Jodi Hwang; Harrison Dermer; Divy Mehra; William Feuer; Anat Galor
Journal:  Ocul Surf       Date:  2021-06-06       Impact factor: 6.268

9.  In vivo confocal microscopy assessment of meibomian glands microstructure in patients with Graves' orbitopathy.

Authors:  Shengnan Cheng; Yueqi Yu; Jin Chen; Lin Ye; Xinghua Wang; Fagang Jiang
Journal:  BMC Ophthalmol       Date:  2021-06-19       Impact factor: 2.209

10.  Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study.

Authors:  Ibrahim Y Allam; Sihem Lazreg; Mohamed Shafik Shaheen; Mohamed Fahmy Doheim; Mai A Mohammed
Journal:  Clin Ophthalmol       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.